(ISSN 2638-1311)
OBM Geriatrics is an Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.
Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.
Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.
Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes research articles, reviews, communications and technical notes. There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 12 days from acceptance to publication (median values for papers published in this journal in 2020, 1-2 days of FREE language polishing time is also included in this period).
Acknowledgement to Reviewers of OBM Geriatrics in 2021Abstract The editors of OBM Geriatrics would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2021. We greatly appreciate the contribution of expert reviewers, which is crucial to [...] |
Adjustment for Covariates of Major Depressive Episodes among Men and Women Aged 65 Years Old and Olderby
Areen Omary
and
TAMEKA CHAMBERS
Abstract The current study aimed to examine if sex can significantly predict risk for lifetime major depressive episodes among adults aged 65 and older with and without adjustment for covariate variables of race, education, marital status, health, and poverty. Secondary data was obtained from the National Su [...] |
The Safety of Oral Telomerase Activator in UV-Induced Skin Cancer with A Review of Telomerase in Aging and Skin CarcinogenesisAbstract The supplement telomerase activator TA-65 (purified from Astragalus membranaceus) has been shown to retard cellular senescence, boost the aging immune system, and retard age-related symptoms. Lengthened telomeres retard aging, but because cancers often maintain longe [...] |
Cisplatin-Based Neoadjuvant Chemotherapy for Elderly Patients with Muscle-Invasive Bladder Cancer: Is It Feasible?by
Clement Dumont
,
Madeleine Lefèvre
,
Quiterie Aussedat
,
Pierre-Louis Régnier
,
Alexandra Masson-Lecomte
,
Evanguelos Xylinas
,
Hélène Gauthier
,
Virginie Fossey-Diaz
,
Amélie Arégui
and
Stéphane Culine
Abstract Cisplatin-based neoadjuvant chemotherapy (C-NAC) has been the standard of care in localized muscle-invasive bladder cancer (MIBC). However, the feasibility and benefit of C-NAC in elderly patients remain uncertain since this population has always been underrepresented in pivotal trials a [...] |
Men's Bones Matter Too, a Cross Sectional Study Examining Bone Health among Men with Intellectual Disability in Ireland.by
Éilish A. Burke
,
Rachael Carroll
,
Angela W. Ding
,
Melisa Yaman
,
J. Bernard Walsh
,
Philip McCallion
and
Mary McCarron
Abstract Globally between 30-40% of all osteoporotic fractures occur among men, with a quarter of all hip fractures, the most serious complication of osteoporosis, occurring in men. Among men of 50 years of age or older, osteoporotic fracture risk reaches an alarming 20%. What is of great concern [...] |
An Overview of Osteoporosis ManagementAbstract Osteoporosis is one of the most common disorders around the world. Osteoporotic fracture especially hip fracture are associated with an increased mortality rate in elders. However, elders with osteoporosis or at high risk of fractures remain largely underdiagnosed and undertreated. The s [...] |
Study of the Development of Carotid Artery Atherosclerosis upon Oxidative Stress using Infrared Spectroscopy and Scanning Electron MicroscopyAbstract In the present study, Fourier-transform infrared (FTIR) spectroscopy and Scanning Electron Microscopy (SEM) were used to investigate the formation and development of carotid artery atherosclerosis. The FTIR spectra showed that with the progression of atheromatic plaque formation, the col [...] |
Surgical Treatment of Zenker’s Diverticulum In Older PatientsAbstract Zenker’s diverticulum is a cause of benign dysphagia. The main symptoms include dysphagia and regurgitation and require diagnostics to exclude neoplastic disease. Surgical treatment is recommended for symptomatic patients. The methods of treatment include endoscopic and open transcervica [...] |
Diagnosis and Therapy of Atrial Fibrillation in Geriatric PatientsAbstract Atrial fibrillation is very common in most old patients who need an adapted therapy due to their comorbidities. Before initiating an antiarrhythmic therapy, possible adverse effects, especially iatrogenic proarrhythmia, and extracardiac side-effects, must be considered. In geriatric pati [...] |
Effect of 12 Months of Oral Exercise on the Oral Function of Older Japanese Adults requiring CareAbstract Objective: The present study aimed to elucidate the relationship between oral exercise and oral function among older adults requiring care in the nursing facilities of Japan. Methodology: The subjects were adults aged 65 year [...] |
Regulation of Membrane Phospholipid Homeostasis in Neurodegenerative Diseasesby
XinRan Quan
and
Marica Bakovic
Abstract Neurodegenerative diseases (NDs) are a diverse group of neuropathological diseases that are currently incurable due to the irreversible neuronal loss. At the present rate of the world population growth, it is projected that the number of ND cases will double by the year of 2050. With tre [...] |
Impact of Osteophytectomy on Swallowing Function in a Patient with Chronic DysphagiaAbstract Anterior cervical osteophytes are common in the geriatric population. Dysphagia can occur in individuals suffering from these spinal abnormalities. Surgical intervention is an uncommon course of treatment for these patients, but is often utilized as a last resort with the hope of swallow [...] |
Dysphagia in the Older Age SettingAbstract Dysphagia, or difficulty swallowing, is a common condition, especially among the elderly population and can become debilitating. As we age, there are subtle changes in esophageal motility, but by no means is dysphagia ever considered to be a normal result of aging. Dysphagia usually pres [...] |
Osteoporosis in Postmenopausal Women with Breast CancerAbstract Breast cancer and osteoporosis are both diseases of aging. The "one in eight" lifetime risks of breast cancer occur primarily in the sixth, seventh, eighth, and ninth decades of life. One-third of postmenopausal women will experience an osteoporotic fracture. It is the coalesce [...] |
The PBAR Protocol: Antipsychotic Medication Reduction in the Nursing HomeAbstract Neuropsychiatric symptoms (NPS) occur in almost all persons living with dementia. Antipsychotic medications are often prescribed inappropriately for persons living with dementia who experience NPS. Adverse side effects of antipsychotic medications include falls, sedation, cognitive dysfu [...] |
Stenting of the esophagus in the course of the malignant dysphagia in elderly patientsAbstract Esophageal cancer is a disease with difficult clinical management, and palliative therapy is the only predominant treatment. This retrospective study analyses the results of clinical management of elderly patients (>75 years of age) who were treated with esoph [...] |
Deep Brain Stimulation – Therapeutic Possibilities in Alzheimer's DiseaseAbstract Alzheimer’s Disease (AD) is the leading cause of dementia worldwide, and represents a significant cause of cognitive decline, disability, and mortality. Ongoing clinical trials continue to investigate β-amyloid targeted therapy with unclear benefit, and we are currently limited to sympto [...] |
Promoting Quality of Life in Advanced Dementia Care: Reading Buddies Program as Service-learningby
Scott A. Trudeau
and
Megan E. Gately
Abstract The Reading Buddies Program was developed as a service-learning component of an Occupational Therapy Practice with Older Adults course as a collaboration between Tufts University and the VA Bedford Health Care System. The purpose of this service-learning program was to challenge graduate [...] |
Double-Blind, Placebo-Controlled, Randomized Clinical Trial Demonstrates Telomerase Activator TA-65 Decreases Immunosenescent CD8+CD28- T Cells in Humansby
Gunasekaran Singaravelu
,
Calvin Harley
,
Joseph Raffaele
,
Pratheesh Sudhakaran Sudhakaran
and
Anitha Suram
Abstract TA-65 is a small molecule telomerase activator extracted from Astragalus species. A previous observational study suggested that TA-65 decreased the number of immunosenescent cells in healthy subjects. Here we examined the impact of TA-65 in a much larger randomized, double-blind, and pla [...] |
Admiral Nurse Case Management within Enhanced Health in Care HomesAbstract The United Kingdom’s (UK) older population is higher than the global average. Over the next 20 years, England will see an increase in the number of older people who have higher levels of dependency, dementia, and comorbidity many of whom may require 24-hour care. Currently It is estimated that 70% o [...] |
The Role of Fatigue in the Aging Swallow: A ReviewAbstract Fatigue is a term commonly used to describe patient performance and/or subjective experience in the evaluation and management of swallowing disorders (known as dysphagia). There is an association between fatigue and aging, as well as fatigue and many dysphagia-causing diseases/disorders. Therefore, [...] |
Translation and Validation of “Brief Bedside Dysphagia Screening Test” in a Greek Sample of Neurological Patientsby
Sophia Demeneopoulou
,
Marianna Mantzorou
,
Petra Mandysova
,
Nikoletta Margari
,
Eleni Dokoutsidou
,
Aggeliki Tsiligianni
,
Chrysoula Tsiou
and
Theodoula Adamakidou
Abstract Background. Dysphagia may be a threatening condition if not diagnosed and treated early.
Healthcare professionals need simple, quick and reliable tools for their daily clinical practice
to be able to evaluate it immediately. The purpose of the present study was the translation
and validation of t [...] |
Molecular Basis of Allogeneic Pluripotent Stem Cell Treatment of a Patient with Sporadic ALSby
Samuel Brennan
,
Matthew Keon
,
Zheng Su
,
Bing Liu
,
Xiao Min Song
,
Thiri Zaw
,
Matthew McKay
,
Donna Pascovici
and
Nitin K. Saksena
Abstract There are no curative strategies for ALS, and as a result the alternative therapies are gaining ground, in particular the stem cell-based therapies which hold a promising future. Here we describe an ALS patient, who by choice, received allogeneic human cord-blood derived multipotent stem cells (MSC) [...] |
Routines and Structure in the Assessment of Visuospatial Neglect in Rehabilitation Facilities: Current Practice in the Netherlands and the United Kingdomby
Martine S. Bosma
,
Monique A.A. Caljouw
,
Jacqueline Benfield
,
Laura Edwards
,
Tanja Nijboer
and
Wilco Achterberg
Abstract Visuospatial neglect (VSN) adversely impacts both the length of rehabilitation and activities of daily living (ADL) of patients after stroke and can reduce their participation in community activities. Therefore, it is important to assess VSN after stroke in neurorehabilitation facilities. The proces [...] |
Research Recommendations to Address Dementia Workforce Development Needsby
Joan Weiss
,
Nina Tumosa
,
Robert Espinoza
,
Elizabeth Bragg
,
Jennifer Craft Morgan
,
Jason Flatt
,
Eleanor S. McConnell
and
Grace Whiting
Abstract This policy paper presents workforce development recommendations for research, clinical care and public stakeholders as they plan future research activities to strengthen the workforce to support the healthcare and social needs of persons living with dementia and their families and caregivers. To cr [...] |
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Prof. Shin Murakami to join the Editorial Board of OBM Geriatrics. Prof. Murakami is a Professor, Department of Basic Sciences, College of Osteopathic Medicine, Touro University California, CA 94592, USA. Prof. Murakami’s main research interests are aging, stress resistance, cognitive functions, Alzheimer’s disease, genetics, geriatrics, genetics and epigenetics of aging, role of metabolism genes in AMI (age-related memory impairment) and dementia, and midlife crisis theory of aging. We are grateful to Prof. Murakami for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Prof. Michele Lanza to join the Editorial Board of OBM Geriatrics. Prof. Lanza is an Associate Professor, Multidisciplinary Department of Medical, Surgical and Dental Sciences, Università della Campania Luigi Vanvitelli, Napoli, Italy. Prof. Lanza’s main research interests are glaucoma, eyes, cataract surgery, clinical ophthalmology, eye diseases, and retinal diseases. We are grateful to Prof. Lanza for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Prof. Pedro Morouco to join the Editorial Board of OBM Geriatrics. Prof. Morouco is an Associate Professor, Department of Human Kinetics, Polytechnic Institute of Leiria, 2411 Leiria, Portugal; CIPER, Faculdade de Motricidade Humana, Universidade de Lisboa, 1495 Cruz Quebrada Dafundo, 1649004 Lisbon, Portugal. Prof. Morouco’s main research interests are exercise and health, sport sciences, elderly, osteoarthritis, exercise physiology, and sports science. We are grateful to Prof. Morouco for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Prof. P. Hemachandra Reddy to join the Editorial Board of OBM Geriatrics. Prof. Reddy is a Professor of Internal Medicine, Neuroscience/Pharmacology, Neurology and Public Health, Texas Tech University Health Sciences Center, Texas 79430, USA. Prof. Reddy’s main research interests are aging, neurodegenerative diseases - Alzheimer’s, Huntington’s, Parkinson’s, oxidative stress, and diabetes/obesity. We are grateful to Prof. Reddy for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Prof. Jacques Vanobbergen to join the Editorial Board of OBM Geriatrics. Prof. Vanobbergen is an Emeritus Professor, Community Dentistry and Oral Public Health, Dental School, Ghent University, Ghent, Belgium. Prof. Vanobbergen’s main research interests are oral health, older adults, oral, and dental public health. We are grateful to Prof. Vanobbergen for the participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Dr. Carlo Pedrolli to join the Editorial Board of OBM Geriatrics. Dr. Pedrolli is from Dietetic and Clinical Nutrition Unit, Santa Chiara Hospital, Azienda Provinciale per i Servizi Sanitari Provincia Autonoma di Trento, Italy. Dr. Pedrolli’s main research interests are nutrition, geriatric nutrition, internal medicine, cardiology, clinical nutrition, malnutrition, nutrition assessment, human nutrition, nutritional medicine, body composition analysis, and dietetics. We are grateful to Dr. Pedrolli for the participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Dr. Koh Iwasaki to join the Editorial Board of OBM Geriatrics. Dr. Iwasaki is the Vice President, Natori Kumanodoh Hospital, Natori, Japan. Dr. Iwasaki’s main research interests are traditional Chinese medicine, stroke, healthcare, traditional medicine, clinical trials, geriatric medicine, phytotherapy and herbal medicine. We are grateful to Dr. Iwasaki for the participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Dr. Ron J. Jankowski to join the Editorial Board of OBM Geriatrics. Dr. Jankowski is the Vice President, Scientific Affairs, Cook MyoSite Inc, Pittsburgh, PA 15238 USA. Dr. Jankowski’s main research interests are utologous muscle derived cells, incontinence, cell therapies, translational medical and biologic product development. We are grateful to Dr. Jankowski for the participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Prof. Giuseppe Cocco to join the Editorial Board of OBM Geriatrics. Prof. Cocco is an Emeritus Professor, Emeritus Fellow of the European Society of Cardiology, Cardiology Office, Marktgasse 10a, CH-4310 Rheinfelden, Switzerland. Prof. Cocco’s main research interests are geriatric cardiology, old cardiac patients, heart failure, geriatric cardiac diseases, noninvasive cardiovascular diagnostics and cardiovascular therapeutics. We are grateful to Prof. Cocco for the participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Prof. Roy G. Beran to join the Editorial Board of OBM Geriatrics. Prof. Beran is a Conjoint Professor of Medicine at the University of NSW; Professor in the School of Medicine at Griffith University, Queensland; and Professor, Chair, Medical Law, Sechenov Moscow 1st State University, Moscow, Russia. He was the inaugural Visiting Professor at the International Research Institute of Health Law Sciences at the Southern Medical University, Guangzhou, Guangdong Province, China and has been a Visiting Professor at Macau University. His main research interests are sleep, health law & ethics, epilepsy, sleep disorders, drug trials, legal medicine, neurological conditions & new therapies, and neurological advances. We are grateful to Prof. Beran for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Dr. David G Smithard to join the Editorial Board of OBM Geriatrics. Dr. Smithard is a Consultant in Elderly and Stroke Medicine, Geriatric Medicine, Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, Woolwich, SE18 4QH, UK; Research Fellow, Department of Sports Science, University of Greenwich, London, SE9 2UG, UK. His main research interests are dysphagia, frailty, care homes, stroke, swallowing rehabilitation and healthy aging. We are grateful to Dr. Smithard for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Professor Fabio Antonaci to join the Editorial Board of OBM Geriatrics. Prof. Antonaci is a Professor of Neurology, Department of Brain and Behavioral Sciences, Mondino National Institute of Neurology Foundation, University of Pavia, Italy. His main research interests are neurophysiology, clinical neurology, neurological disorders, neurological diseases, pain medicine, neurology, neurologic examination, clinical neurophysiology, pain and pain management in the elderly. We are grateful to Prof. Antonaci for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Professor Donatella R. Petretto to join the Editorial Board of OBM Geriatrics. Dr. Petretto is a Professor at the Section on Clinical Psychology, Department of Education, Psychology, Philosophy, University of Cagliari, Cagliari, Italy. His main research interests are active ageing, successful ageing, oldest olds, cognitive functioning, well-being, participation, disability and disablement. We are grateful to Dr. Petretto for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Miyako Tazaki to join the Editorial Board of OBM Geriatrics. Dr. Tazaki is a Professor at the Department of psychology, Faculty of Medicine, Toho University, Tokyo, Japan. Her main research interests are dementia, elderly, disability and psychology. We are grateful to Dr. Tazaki for her participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Dr. Khue Vu Nguyen to join the Editorial Board of OBM Geriatrics. Dr. Nguyen is a Full Project Scientist in Departments of Medicine and Pediatrics, University of California, San Diego, California, USA. His main research interests are molecular biology, genetic diseases, enzymology, biosensors, biopolymers, neurodevelopmental and neurodegenerative disorders, and cancer. We are grateful to Dr. Nguyen for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Professor James S. Powers to join the Editorial Board of OBM Geriatrics. Dr. Powers is a Professor at the Department of Medicine, Vanderbilt University School of Medicine, USA and Clinical Associate Director, Tennessee Valley Healthcare System Geriatrics Research Education and Clinical Center. His main research interests are accidental falls, delirium, dementia, geriatric consultation, geriatric syndromes, and geriatric models of care. We are grateful to Dr. Powers for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Dr. E. Paul Cherniack from University of Miami Miller School of Medicine, USA, to join the Editorial Board of OBM Geriatrics. Dr. Cherniack’s main research interests are nutrition, frailty, vitamin D, and alternative medicine in the elderly. We are grateful to Dr. Cherniack for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Dr. Johannes Grillari from BOKU University of Natural Resources and Life Sciences, Austria, to join the Editorial Board of OBM Geriatrics. Dr. Grillari is an Associate Professor at Department of Biotechnology, BOKU University of Natural Resources and Life Sciences, Austria. His main research interests are cellular aging, replicative senescence, RNA biology, pre-mRNA splicing, non-coding RNA miRNA, Vesicle secretion, DNA damage and repair and Ubiquitin-proteasome. We are grateful to Dr. Grillari for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We sincerely welcome Dr. Claudia Voelcker-Rehage to join the Editorial Board of OBM Geriatrics. Dr. Voelcker-Rehage is professor of Sports Psychology at Technische Universität Chemnitz. Her research focuses on lifespan motor development and learning, the connection between motor and cognitive performance, and interventions in order to maintain and improve motor and cognitive functioning in older adults as well as to promote lifelong development. We appreciate Dr. Voelcker-Rehage for her participation and support!
OBM Geriatrics Welcomes New Editorial Board Member
We sincerely welcome Professor George Perry, Dean of the College of Sciences, in the University of Texas at San Antonio, USA, to join the Editorial Board of OBM Geriatrics. Professor Perry’s studies are focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease. He is a leading scholar with profound expertise and extensive publications regarding his research. We appreciate Professor Perry's participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We sincerely welcome Dr. Donald A. Jurivich to join the Editorial Board of OBM Geriatrics. Dr. Jurivich is Eva Gilbertson, MD Distinguished Chair of Geriatrics at the University of North Dakota School of Medicine and Health Sciences. He is also a well-known clinician with expertise in immunology, stress, physical activity and exercise. We appreciate Dr. Jurivich for his participation and support!
OBM Geriatrics Welcomes New Editorial Board Member
We welcome Prof. William M. Petrie to join the Editorial Board of OBM Geriatrics. Prof. Petrie is
a professor of Clinical Psychiatry and Behavioral Sciences in the School of Medicine at the Vanderbilt University. His areas of expertise are geriatric psychiatry, geriatric assessment, clinical psychiatry, psychopharmacology, etc. We are grateful to Prof. Petrie for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We sincerely welcome Dr. Chas Bountra to join the Editorial Board of OBM Geriatrics. Dr. Bountra is Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and Associate Member of the Department of Pharmacology at the University of Oxford. He has participated in the identification of over 40 clinical candidate molecules for many diseases. We appreciate Dr. Chas Bountra for his participation and support!
OBM Geriatrics Welcomes New Editorial Board Member
We sincerely welcome Professor Gilles Berrut to join the Editorial Board of OBM Geriatrics.
Pr. Berrut is a Professor at Nantes University Hospital, who founded Gérontopôle Pays de la Loire in 2010. President of French Geriatric Society in 2009-2011, member of council of the International Association of Gerontology and Geriatrics, Pr. Berrut is a leader in geriatric research at the university, and has great research achievements in biology of aging and geriatrics. We appreciate Pr. Berrut’s participation and support!
OBM Geriatrics Welcomes New Editorial Board Member
We sincerely welcome Dr. Rocío Fernández-Ballesteros to join the Editorial Board of OBM Geriatrics. Dr. Fernández-Ballesteros is an Emeritus Professor at Autonomous University of Madrid. She is well-known for her scientific achievements in psychology of aging. We appreciate Dr. Fernández-Ballesteros for her participation and support!
OBM Geriatrics Welcomes New Editorial Board Member
We sincerely welcome Dr. Patrick Kehoe to join the Editorial Board of OBM Geriatrics. Dr. Kehoe is a professor of Translational Dementia Research at University of Bristol. His expertise covers the development of Alzheimer's disease and other dementias, particularly the role of renin angiotensin system in the pathology of Alzheimer's disease. We appreciate Dr. Kehoe's participation and support!
OBM Geriatrics Welcomes New Editorial Board Member
We sincerely welcome Dr. Frieda R. Butler, Professor Emerita at George Mason University, to join the Editorial Board of OBM Geriatrics. Dr. Butler has served as consultant, gerontological authority and health advisor to numerous agencies and organizations. Her research areas include long-term care; behavioral problems in nursing homes residents; wellness promotion; end-of-life care; grandparents parenting grandchildren; dementia and other related topics. We appreciate Dr. Butler for her participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We sincerely welcome Dr. Volodymyr Mavrych to join the Editorial Board of OBM Geriatrics. Dr. Mavrych is a Professor of Neuroscience at St. Matthew's University, and a Senior Fellow at New Westminster College. He is skilled in gross anatomy and osteology, and has published intensively on age-related changes in the lumbar vertebrae. We appreciate Dr. Mavrych for his participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We sincerely welcome Professor Åke Wahlin from Jönköping University School of Health and Welfare to join the Editorial Board of OBM Geriatrics. Professor Wahlin is an eminent gerontologist, whose research concentrates on cognitive psychology, including age-related cognitive abilities and functioning. We appreciate Professor Wahlin's participation and support.
OBM Geriatrics Welcomes New Editorial Board Member
We sincerely welcome Dr. Heike Anderson-Schmidt to join the Editorial Board of OBM Geriatrics. Dr. Anderson-Schmidt is an active researcher at University Medical Center Goettingen and Clinical Research Group 241. She has a great deal of expertise in psychopathology and is training as a psychotherapist. We appreciate Dr. Anderson-Schmidt for her participation and support.
The development of the next generation of Alzheimer’s disease treatments is among the most important health needs worldwide, but presents huge challenges. The goal of the meeting is to bring together today’s worldwide leaders in the treatment of Alzheimer’s disease to discuss new results, candidate therapeutics, and methodological issues important to the development of the next generation of Alzheimer’s disease treatments.
Clinical trial teams from worldwide centers will report on their efforts to identify new biomarkers of disease as well as more sensitive clinical assessment tools to identify those at risk for AD, to predict progression, and assess the effectiveness of new treatments.
For more details, please visit: https://www.ctad-alzheimer.com/ctad-2020
AAIC 2020 will bring together international investigators, clinicians and care researchers to discuss the latest studies, theories and discoveries that will help bring the world closer to breakthroughs in dementia science.
For more details, please visit: https://www.alz.org/aaic/overview.asp
Who: Providers of all disciplines who are passionate about or interested in regenerative medicine are encouraged to attend this event. The agenda will be packed full of actionable topics that most attendees will be able to put into effect immediately to continue to provide their patients with the most cutting-edge therapies.
What: Integrative Regen Group’s second conference will be bringing together experts in all areas of regenerative medicine, from stem cells to photobiomodulation, peptides to hormones, and everything in between. It is our goal that every person in attendance increase their knowledge base substantially.
For more details, please visit: https://www.intregengroup.com/
With rapid advances in the understanding of the underlying biology and mechanisms of aging, ground-breaking research and technology are coming together to target aging pathways, in a way to prevent, reverse or delay the onset of age-related conditions, and consequently improve heathspan.
The 2nd Longevity Therapeutics 2020 Summit will once again bring together 80+ leading experts in aging-related research, including biotechs, pharma, academics and investors, who are committed to serving worldwide population with innovative drugs to prevent, delay and treat age-related conditions.
For more details, please visit: https://longevity-therapeutics.com/
OBM Geriatrics welcomes the following types of articles: original research, review, communication, opinion, case report, comment, conference report, technical note, book review, etc. There is no restriction on the length of the papers, color figures, supplementary file types. More details please see Instructions for Authors.
Highlight
by Michael Fossel
OBM Geriatrics 2022
Published: 15 January 2020
Highlight from: A unified model of dementias and age‐related neurodegeneration.
Michael Fossel.
Alzheimer’s & Dementia.
doi: 10.1002/alz.12012.
Case Report
by Garuth Chalfont et al.
OBM Geriatrics 2022
Published: 07 August 2019
Perspective
by Robert Conder et al.
OBM Geriatrics 2022
Published: 20 March 2019
Review
by Michael Fossel
OBM Geriatrics 2022
Published: 15 February 2019
TOP
